Literature DB >> 9427705

High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation.

G Motta1, R Rojkjaer, A A Hasan, D B Cines, A H Schmaier.   

Abstract

The consequences of assembling the contact system of proteins on the surface of vascular cells has received little study. We asked whether assembly of these proteins on the surface of cultured human endothelial cells (HUVECs) results in the activation of prekallikrein (PK) and its dependent pathways. Biotinylated PK binds specifically and reversibly to HUVECs in the presence of high molecular weight kininogen (HK) (apparent Kd of 23 +/- 11 nmol/L, Bmax of 1.7 +/- 0.5 x 10(7) sites per cell [mean +/- SD, n = 5 experiments]). Cell-associated PK is rapidly converted to kallikrein. Surprisingly, the activation of cell-associated HK.PK complexes is entirely independent of exogenous factor XII (Km = 30 nmol/L, Vmax = 12 +/- 3 pmol/L/min in the absence v Km = 20 nmol/L, Vmax = 9.2 +/- 2.1 pmol/L/min in the presence of factor XII). Rather, kallikrein formation is mediated by an endothelial cell-associated, thiol protease. Cell-associated HK is proteolyzed during the course of prekallikrein activation, releasing kallikrein from the surface. Furthermore, activation of PK bound to HK on HUVECs promotes kallikrein-dependent activation of pro-urokinase, resulting in the formation of plasmin. These results indicate the existence of a previously undescribed, factor XII-independent pathway for contact factor activation on HUVECs that regulates the production of bradykinin and may contribute to cell-associated plasminogen activation in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9427705

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

Review 1.  The plasma kallikrein-kinin system counterbalances the renin-angiotensin system.

Authors:  Alvin H Schmaier
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 2.  New insights into insulin action and resistance in the vasculature.

Authors:  Camila Manrique; Guido Lastra; James R Sowers
Journal:  Ann N Y Acad Sci       Date:  2014-03-20       Impact factor: 5.691

3.  Physiologic activities of the contact activation system.

Authors:  Alvin H Schmaier
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 4.  Diabetic retinopathy: Breaking the barrier.

Authors:  Randa S Eshaq; Alaa M Z Aldalati; J Steven Alexander; Norman R Harris
Journal:  Pathophysiology       Date:  2017-07-12

Review 5.  The initiation and effects of plasma contact activation: an overview.

Authors:  Lisha Lin; Mingyi Wu; Jinhua Zhao
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

6.  Novel mechanism of plasma prekallikrein (PK) activation by vascular smooth muscle cells: evidence of the presence of PK activator.

Authors:  J S Keum; M A Jaffa; L M Luttrell; A A Jaffa
Journal:  J Biol Regul Homeost Agents       Date:  2014 Oct-Dec       Impact factor: 1.711

7.  Activation of the contact system at the surface of Fusobacterium necrophorum represents a possible virulence mechanism in Lemièrre's syndrome.

Authors:  Karin Holm; Inga-Maria Frick; Lars Björck; Magnus Rasmussen
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

8.  Active plasma kallikrein localizes to mast cells and regulates epithelial cell apoptosis, adipocyte differentiation, and stromal remodeling during mammary gland involution.

Authors:  Jennifer N Lilla; Ravi V Joshi; Charles S Craik; Zena Werb
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

9.  Streptococcus sanguis-induced platelet clotting in rabbits and hemodynamic and cardiopulmonary consequences.

Authors:  M W Meyer; K Gong; M C Herzberg
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.

Authors:  N J Mutch; E K Waters; J H Morrissey
Journal:  J Thromb Haemost       Date:  2012-10       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.